The US biotechnology market offers immense opportunities, but traditionally at a steep cost: partnering with Big Pharma or losing control. A new approach is emerging, allowing biotech firms to establish a strong US presence while preserving independence. This guide explores innovative strategies for transatlantic expansion that maintain equity and vision, from setting up subsidiaries to navigating regulations. Learn how to succeed in America without sacrificing your company's essence.
